|
US3906092A
(en)
*
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
|
GB2134869A
(en)
|
1983-02-15 |
1984-08-22 |
Squibb & Sons Inc |
Method of preparing liposomes and products produced thereby
|
|
US4610868A
(en)
*
|
1984-03-20 |
1986-09-09 |
The Liposome Company, Inc. |
Lipid matrix carriers for use in drug delivery systems
|
|
US6090406A
(en)
*
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5897873A
(en)
*
|
1984-04-12 |
1999-04-27 |
The Liposome Company, Inc. |
Affinity associated vaccine
|
|
US5550289A
(en)
|
1985-01-07 |
1996-08-27 |
Syntex (U.S.A.) Inc. |
N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4806352A
(en)
*
|
1986-04-15 |
1989-02-21 |
Ribi Immunochem Research Inc. |
Immunological lipid emulsion adjuvant
|
|
US4803070A
(en)
*
|
1986-04-15 |
1989-02-07 |
Ribi Immunochem Research Inc. |
Immunological emulsion adjuvants for polysaccharide vaccines
|
|
US4806350A
(en)
*
|
1986-04-18 |
1989-02-21 |
Norden Laboratories, Inc. |
Vaccine formulation
|
|
US5084269A
(en)
*
|
1986-11-06 |
1992-01-28 |
Kullenberg Fred W |
Adjuvant for dose treatment with antigens
|
|
US4920016A
(en)
*
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US6093406A
(en)
*
|
1988-06-02 |
2000-07-25 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccine for induction of immunity to malaria
|
|
CA2017507C
(en)
*
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
FR2649013B1
(fr)
*
|
1989-07-03 |
1991-10-25 |
Seppic Sa |
Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
|
|
US5015476A
(en)
*
|
1989-08-11 |
1991-05-14 |
Paravax, Inc. |
Immunization implant and method
|
|
US5013556A
(en)
*
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
CA2082155C
(en)
|
1990-05-29 |
2008-04-15 |
Krishnaswamy I. Dayalu |
Swine pneumonia vaccine and method of preparation
|
|
US5709879A
(en)
*
|
1990-06-29 |
1998-01-20 |
Chiron Corporation |
Vaccine compositions containing liposomes
|
|
BR9106604A
(pt)
|
1990-06-29 |
1993-06-22 |
Chiron Corp |
Composicao de vacina e processo para estimular uma resposta imunologica em um animal hospedeiro
|
|
JPH06503559A
(ja)
|
1990-12-12 |
1994-04-21 |
ザ・ユニバーシティ・オブ・クイーンズランド |
サブユニット・パピローマウイルス・ワクチンおよびそれに使用するペプチド
|
|
CA2072249C
(en)
|
1991-06-28 |
2003-06-17 |
Saiko Hosokawa |
Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
|
|
EP0598813A4
(en)
|
1991-08-13 |
1994-09-14 |
Biotech Australia Pty Ltd |
Immunostimulation.
|
|
US6037135A
(en)
*
|
1992-08-07 |
2000-03-14 |
Epimmune Inc. |
Methods for making HLA binding peptides and their uses
|
|
RU94040856A
(ru)
|
1992-03-03 |
1996-08-20 |
Дайити Фармасьютикал Ко. |
Вакцина для перорального введения
|
|
US5855894A
(en)
*
|
1992-03-30 |
1999-01-05 |
Pfizer Inc. |
Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
|
|
WO1993025231A1
(en)
|
1992-06-05 |
1993-12-23 |
Dalhousie University |
Use of zona pellucida glycoproteins for immunocontraception
|
|
US5736141A
(en)
*
|
1992-06-05 |
1998-04-07 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
|
|
USRE37224E1
(en)
*
|
1992-06-05 |
2001-06-12 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
|
|
SI9300468A
(en)
*
|
1992-10-14 |
1994-06-30 |
Hoffmann La Roche |
Injectable composition for the sustained release of biologically active compounds
|
|
US5820879A
(en)
*
|
1993-02-12 |
1998-10-13 |
Access Pharmaceuticals, Inc. |
Method of delivering a lipid-coated condensed-phase microparticle composition
|
|
JPH06247842A
(ja)
*
|
1993-02-23 |
1994-09-06 |
Green Cross Corp:The |
リポソーム組成物の製造方法
|
|
JPH09502086A
(ja)
|
1993-08-06 |
1997-03-04 |
サイテル コーポレイション |
完全ｍａｇｅ１遺伝子のクローニング及び特性決定
|
|
US20050049197A1
(en)
|
1993-09-14 |
2005-03-03 |
Epimmune Inc. |
Induction of immune response against desired determinants
|
|
DE69533693T2
(de)
|
1994-02-24 |
2005-12-22 |
Novavax Inc.(n.d.Ges.d.Staates Delaware) |
Impfstoffe, die paucilamelläre Lipidvesikel als Adjuvans enthalten
|
|
US5874560A
(en)
|
1994-04-22 |
1999-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Melanoma antigens and their use in diagnostic and therapeutic methods
|
|
ATE196297T1
(de)
|
1994-05-18 |
2000-09-15 |
Synthetic Peptides Inc |
Heterodimere trägerzusammensetzung von immunogenen polypeptiden und verfahren zu deren verwendung
|
|
US6355247B1
(en)
*
|
1994-06-02 |
2002-03-12 |
Chiron Corporation |
Nucleic acid immunization using a virus-based infection/transfection system
|
|
US5688772A
(en)
|
1994-08-01 |
1997-11-18 |
University Of Saskatchewan |
Quinoa saponin compositions and methods of use
|
|
US5637300A
(en)
*
|
1994-08-03 |
1997-06-10 |
Dunbar; Bonnie S. |
Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception
|
|
US6355256B1
(en)
|
1994-09-30 |
2002-03-12 |
Ludwig Institute For Cancer Research |
Compositions containing a p53 derived protein or peptide, an adjuvant, and interleukin-12 and uses thereof
|
|
FR2726764B1
(fr)
*
|
1994-11-14 |
1997-01-31 |
Pasteur Merieux Serums Vacc |
Adjuvant pour composition vaccinale
|
|
GB9422990D0
(en)
|
1994-11-15 |
1995-01-04 |
Cortecs Ltd |
Immunogenic compositions
|
|
FR2732895B1
(fr)
*
|
1995-04-11 |
1997-05-16 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
|
|
US6846489B1
(en)
*
|
1995-04-25 |
2005-01-25 |
Smithkline Beecham Biologicals S.A. |
Vaccines containing a saponin and a sterol
|
|
US5705151A
(en)
*
|
1995-05-18 |
1998-01-06 |
National Jewish Center For Immunology & Respiratory Medicine |
Gene therapy for T cell regulation
|
|
AU6330896A
(en)
*
|
1995-06-07 |
1996-12-30 |
Governors Of The University Of Alberta, The |
A method for eliciting a th1-specific immune response
|
|
JP3098401B2
(ja)
|
1995-07-12 |
2000-10-16 |
株式会社エルティーティー研究所 |
経鼻投与用製剤
|
|
US5840839A
(en)
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
|
US6096313A
(en)
*
|
1996-02-09 |
2000-08-01 |
Ludwig Institute For Cancer Research |
Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
|
|
US7019112B1
(en)
*
|
1996-03-19 |
2006-03-28 |
University Of Virginia Patent Foundation |
Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor
|
|
CA2259469A1
(en)
*
|
1996-06-05 |
1997-12-11 |
Ashmont Holdings Limited |
Injectable compositions
|
|
US5919480A
(en)
*
|
1996-06-24 |
1999-07-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposomal influenza vaccine composition and method
|
|
US6284267B1
(en)
*
|
1996-08-14 |
2001-09-04 |
Nutrimed Biotech |
Amphiphilic materials and liposome formulations thereof
|
|
US5910306A
(en)
*
|
1996-11-14 |
1999-06-08 |
The United States Of America As Represented By The Secretary Of The Army |
Transdermal delivery system for antigen
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
US20060002949A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
|
CA2203843C
(en)
*
|
1997-04-28 |
2013-07-23 |
Her Majesty The Queen, In Right Of Canada, As Represented By The Ministe R Of National Defence |
Liposome-encapsulated poly iclc
|
|
US6080725A
(en)
*
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
|
US6110492A
(en)
*
|
1997-05-28 |
2000-08-29 |
Jenner Biotherapies, Inc. |
Immunogenic compositions
|
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
JP2001513982A
(ja)
*
|
1997-08-29 |
2001-09-11 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
フォリスタチン−３
|
|
GB9718901D0
(en)
*
|
1997-09-05 |
1997-11-12 |
Smithkline Beecham Biolog |
Vaccine
|
|
US6291430B1
(en)
*
|
1997-09-12 |
2001-09-18 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US6183746B1
(en)
*
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
AUPP060097A0
(en)
*
|
1997-11-28 |
1998-01-08 |
Commonwealth Scientific And Industrial Research Organisation |
Adjuvant system for enhanced response
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
WO1999030737A1
(en)
*
|
1997-12-16 |
1999-06-24 |
Chiron Corporation |
Use of microparticles combined with submicron oil-in-water emulsions
|
|
AU760549B2
(en)
|
1998-04-03 |
2003-05-15 |
University Of Iowa Research Foundation, The |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
|
US6588671B2
(en)
|
1998-04-09 |
2003-07-08 |
Dcard, Inc. |
Positioning of a recording head for a data storage device
|
|
SE9801288D0
(sv)
*
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
|
US6472375B1
(en)
*
|
1998-04-16 |
2002-10-29 |
John Wayne Cancer Institute |
DNA vaccine and methods for its use
|
|
US6632447B1
(en)
|
1998-05-07 |
2003-10-14 |
The University Of Tennessee Research Corporation |
Method for chemoprevention of prostate cancer
|
|
NZ508013A
(en)
*
|
1998-05-07 |
2003-08-29 |
Corixa Corp |
Adjuvant composition for use with an antigen in a vaccine composition
|
|
US6406719B1
(en)
*
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
|
GB9810236D0
(en)
*
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
|
IL139700A
(en)
*
|
1998-06-15 |
2005-09-25 |
Altarex Medical Corp |
Immunotherapeutic composition for the treatment of prostate cancer
|
|
US20030044454A1
(en)
*
|
1998-06-30 |
2003-03-06 |
Masaru Fukui |
Compositions containing liposomes and/or emulsions and process for the preparation thereof
|
|
FR2781160B1
(fr)
*
|
1998-07-03 |
2000-08-18 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique pour adjuver un vaccin sous-unitaire
|
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
|
US7087236B1
(en)
*
|
1998-09-01 |
2006-08-08 |
Merrion Research I Limited |
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
|
|
US20050084524A1
(en)
*
|
1998-09-30 |
2005-04-21 |
Alza Corporation |
Method for potentiating activity of a chemotherapeutic drug
|
|
US6787154B2
(en)
*
|
1998-10-20 |
2004-09-07 |
Salvatore Albani |
Artificial antigen presenting cells
|
|
GB2345010B
(en)
|
1998-12-17 |
2002-12-31 |
Electrosols Ltd |
A delivery device
|
|
US6790457B1
(en)
*
|
1998-12-22 |
2004-09-14 |
Dalhousie University |
Compositions and methods for reducing or preventing fertilization in fish and birds
|
|
EP1140151A2
(en)
|
1998-12-22 |
2001-10-10 |
Dalhousie University |
Compositions and methods for reducing or preventing fertilization in fish and birds
|
|
AU769539B2
(en)
*
|
1999-01-29 |
2004-01-29 |
Zoetis Services Llc |
Adjuvants for use in vaccines
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
PT1187629E
(pt)
*
|
1999-04-19 |
2005-02-28 |
Glaxosmithkline Biolog Sa |
Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
|
|
NZ515322A
(en)
|
1999-05-13 |
2004-03-26 |
Wyeth Corp |
Adjuvant combination formulations
|
|
US6670195B1
(en)
|
1999-05-26 |
2003-12-30 |
New York University |
Mutant genes in Familial British Dementia and Familial Danish Dementia
|
|
NZ515644A
(en)
|
1999-06-04 |
2004-12-24 |
Skyepharma Inc |
Oil-core compositions for the sustained release of hydrophobic drugs
|
|
GB9923176D0
(en)
*
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
|
PT1221968E
(pt)
|
1999-10-13 |
2010-04-16 |
Novartis Vaccines & Diagnostic |
Processo de obtenção de respostas imunes celulares de proteínas
|
|
US6605696B1
(en)
*
|
1999-10-22 |
2003-08-12 |
Pfizer, Inc. |
Lawsonia intracellularis proteins, and related methods and materials
|
|
US6511676B1
(en)
*
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
US6248353B1
(en)
|
1999-12-10 |
2001-06-19 |
Dade Behring Inc. |
Reconstitution of purified membrane proteins into preformed liposomes
|
|
US7026443B1
(en)
|
1999-12-10 |
2006-04-11 |
Epimmune Inc. |
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
|
|
US6602510B1
(en)
|
2000-04-05 |
2003-08-05 |
Epimmune Inc. |
HLA class I A2 tumor associated antigen peptides and vaccine compositions
|
|
WO2001070663A2
(en)
|
2000-03-17 |
2001-09-27 |
Corixa Corporation |
Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
|
|
US6228648B1
(en)
*
|
2000-03-17 |
2001-05-08 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of ADAM10 expression
|
|
EP1286693A4
(en)
|
2000-06-02 |
2005-07-13 |
Univ Connecticut Health Ct |
COMPLEXES OF ALPHA (2) MACROGLOBULIN AND ANTIGENIC MOLECULES FOR USE IN IMMUNOTHERAPY
|
|
AT410173B
(de)
|
2000-06-08 |
2003-02-25 |
Cistem Biotechnologies Gmbh |
Antigene zusammensetzung
|
|
DE60117164T2
(de)
*
|
2000-11-07 |
2006-08-03 |
Immuno Vaccine Technologies Inc., Halifax |
Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
|
|
AU2002219998B2
(en)
|
2000-12-01 |
2006-03-02 |
Biomira, Inc. |
Preparation of large liposomes by infusion into peg
|
|
AU2002219711B8
(en)
|
2000-12-08 |
2006-03-02 |
Academisch Ziekenhuis Leiden |
Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
|
|
US20030045467A1
(en)
*
|
2001-01-05 |
2003-03-06 |
Tihamer Orban |
Autoantigen composition
|
|
US6497896B2
(en)
|
2001-02-12 |
2002-12-24 |
Supergen, Inc. |
Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
|
|
CN1168740C
(zh)
*
|
2001-04-04 |
2004-09-29 |
上海美恩生物技术有限公司 |
细胞因子基因修饰的抗原提呈细胞/肿瘤细胞偶联物、其制法和用途
|
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
US20050037061A1
(en)
*
|
2001-07-25 |
2005-02-17 |
Saiko Hosokawa |
Remedies for mammary cancer
|
|
ATE488249T1
(de)
*
|
2001-07-31 |
2010-12-15 |
Univ Washington |
Immunologisch bedeutende herpes-simplex-virus- antigene und verfahren für ihre verwendung
|
|
GB0127564D0
(en)
*
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
|
US6517816B1
(en)
|
2001-12-26 |
2003-02-11 |
Avon Products, Inc. |
Sunscreen emulsion composition and method of use
|
|
EP1474447A2
(en)
|
2002-02-08 |
2004-11-10 |
Immunovaccine Technologies Inc. |
Antigens for immunocontraception
|
|
US7056515B2
(en)
*
|
2002-02-08 |
2006-06-06 |
Immunovaccine Technologies Inc. |
Antigens for immunocontraception
|
|
US20030220284A1
(en)
|
2002-02-22 |
2003-11-27 |
Patricia Yotnda |
Delivery of adenoviral DNA in a liposomal formulation for treatment of disease
|
|
JP2005535627A
(ja)
|
2002-06-25 |
2005-11-24 |
シティ・オブ・ホープ |
アジュバント不含ペプチド・ワクチン
|
|
US20040213837A1
(en)
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
|
CN1289142C
(zh)
*
|
2002-08-09 |
2006-12-13 |
中国科学院上海生命科学研究院 |
含sa脂质体作为药物载体的药物新剂型
|
|
AU2003268087A1
(en)
|
2002-08-23 |
2004-03-11 |
Ian Ma |
Liposomal gemcitabine compositions for better drug delivery
|
|
EP1393720A1
(en)
*
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesicle-encapsulated corticosteroids for treatment of cancer
|
|
US7179645B2
(en)
|
2002-09-24 |
2007-02-20 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
|
DE10249401A1
(de)
|
2002-10-23 |
2004-05-13 |
Bernina Biosystems Gmbh |
Liposomen formende Zusammensetzung
|
|
US20050158375A1
(en)
*
|
2002-11-15 |
2005-07-21 |
Toshikiro Kimura |
Pharmaceutical composition containing liposomes for treating cancer
|
|
WO2004052917A2
(en)
|
2002-12-10 |
2004-06-24 |
Epimmune Inc. |
Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions
|
|
JP5102959B2
(ja)
|
2002-12-23 |
2012-12-19 |
ダイナバックス テクノロジーズ コーポレイション |
免疫刺激配列オリゴヌクレオチド及びその使用方法
|
|
EP2263687B1
(en)
|
2002-12-27 |
2015-03-25 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic compositions containing phospholipid
|
|
US20040223977A1
(en)
|
2003-02-03 |
2004-11-11 |
City Of Hope |
Fusion peptide HIV vaccines
|
|
EA200501285A1
(ru)
|
2003-02-11 |
2006-02-24 |
Неофарм, Инк. |
Способ получения липосомальных препаратов
|
|
EP1611153B1
(en)
*
|
2003-04-02 |
2010-06-16 |
Board Of Regents, The University Of Texas System |
Antitumor effect of mutant bik
|
|
AU2004226591B2
(en)
|
2003-04-04 |
2009-06-04 |
Zoetis Services Llc |
Microfluidized oil-in-water emulsions and vaccine compositions
|
|
PT1620456E
(pt)
|
2003-04-18 |
2014-04-15 |
Biotech Synergy Inc |
Péptidos antigénicos hla-a2 associados a tumor e suas composições
|
|
WO2005000272A1
(en)
*
|
2003-06-04 |
2005-01-06 |
Isis Pharmaceuticals, Inc. |
Long-circulating liposomal compositions
|
|
US20050013812A1
(en)
|
2003-07-14 |
2005-01-20 |
Dow Steven W. |
Vaccines using pattern recognition receptor-ligand:lipid complexes
|
|
WO2005019435A2
(en)
|
2003-08-26 |
2005-03-03 |
Board Of Regents, The University Of Texas System |
Anti-cancer vaccines
|
|
US20050220781A1
(en)
|
2003-09-04 |
2005-10-06 |
Duen-Hwa Yan |
IFIX, a novel HIN-200 protein, for cancer therapy
|
|
GB0321615D0
(en)
|
2003-09-15 |
2003-10-15 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
GB0323965D0
(en)
*
|
2003-10-13 |
2003-11-19 |
Glaxosmithkline Biolog Sa |
Immunogenic compositions
|
|
US20050266066A1
(en)
|
2003-10-20 |
2005-12-01 |
Nof Corporation |
Phospholipid membrane preparation
|
|
US20050175683A1
(en)
*
|
2003-10-24 |
2005-08-11 |
Yuanpeng Zhang |
Preparation of lipid particles
|
|
DE602004021713D1
(de)
*
|
2003-11-14 |
2009-08-06 |
Het Nl Kanker I The Netherland |
Pharmazeutische formulierungen mit kurzketten-sphingolipiden und ihre verwendung
|
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
|
AU2005222776A1
(en)
|
2003-12-31 |
2005-09-29 |
Genimmune N.V. |
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
|
|
EP1711208A2
(en)
|
2004-01-28 |
2006-10-18 |
Curix APS |
Conjugates of amyloid proteins as vaccines for amyloid-related diseases
|
|
DK1737966T3
(da)
|
2004-04-02 |
2012-07-09 |
Univ Texas |
Cancerspecifik promotorer
|
|
KR20110132416A
(ko)
|
2004-04-05 |
2011-12-07 |
화이자 프로덕츠 인코포레이티드 |
미세유체화된 수중유 유화액 및 백신 조성물
|
|
GB0408164D0
(en)
*
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
CA2563533C
(en)
|
2004-04-15 |
2013-10-01 |
Shmuel A. Ben-Sasson |
Compositions capable of facilitating penetration across a biological barrier
|
|
EP1750673B1
(en)
*
|
2004-05-17 |
2009-12-02 |
Tekmira Pharmaceuticals Corporation |
Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
|
|
WO2006050155A2
(en)
|
2004-10-29 |
2006-05-11 |
Biomune, Inc. |
Cancer therapeutic compositions
|
|
US8337815B2
(en)
|
2004-12-23 |
2012-12-25 |
Discovery Laboratories, Inc. |
Pulmonary surfactant formulations
|
|
EP1838338A2
(en)
|
2004-12-29 |
2007-10-03 |
Mannkind Corporation |
Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
|
|
CA2605068A1
(en)
*
|
2005-04-15 |
2006-10-26 |
The Board Of Regents Of The University Of Texas System |
Delivery of sirna by neutral lipid compositions
|
|
US20060275777A1
(en)
|
2005-06-03 |
2006-12-07 |
Waelti Ernst R |
Novel strategies for protein vaccines
|
|
US8703095B2
(en)
*
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
|
WO2007022152A2
(en)
*
|
2005-08-15 |
2007-02-22 |
The Research Foundation Of State University Of New York |
Lipid nano particulates containing antigens as cancer vaccines
|
|
CA2523032A1
(en)
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
|
WO2007067517A2
(en)
|
2005-12-07 |
2007-06-14 |
Hemispherx Biopharma |
Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants
|
|
KR101515078B1
(ko)
|
2005-12-22 |
2015-04-24 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
|
EP1989224B1
(en)
*
|
2006-02-24 |
2010-10-20 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Immunogenic peptides and methods of use
|
|
US8431160B2
(en)
*
|
2006-02-24 |
2013-04-30 |
Novartis Ag |
Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
|
|
EP2441469A1
(en)
*
|
2006-03-14 |
2012-04-18 |
Oregon Health and Science University |
Methods for producing an immune response to tuberculosis
|
|
WO2007117469A2
(en)
|
2006-03-30 |
2007-10-18 |
The Research Foundation Of State University Of New York |
Compositions of less immunogenic and long-circulating protein-lipid complexes
|
|
EP2040745B1
(en)
|
2006-06-28 |
2012-12-05 |
Statens Serum Institut |
Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
|
|
US20080014217A1
(en)
*
|
2006-07-17 |
2008-01-17 |
Emmanuel Jules Hanon |
Influenza vaccine
|
|
US8877206B2
(en)
*
|
2007-03-22 |
2014-11-04 |
Pds Biotechnology Corporation |
Stimulation of an immune response by cationic lipids
|
|
CN106310293A
(zh)
*
|
2007-09-27 |
2017-01-11 |
免疫疫苗技术有限公司 |
在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
|
|
CA2700828C
(en)
|
2007-10-03 |
2017-01-24 |
Immunovaccine Technologies Inc. |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|